Growth Metrics

Wave Life Sciences (WVE) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $196.2 million.

  • Wave Life Sciences' Cash & Current Investments fell 3689.68% to $196.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $196.2 million, marking a year-over-year decrease of 3689.68%. This contributed to the annual value of $302.1 million for FY2024, which is 5077.44% up from last year.
  • Wave Life Sciences' Cash & Current Investments amounted to $196.2 million in Q3 2025, which was down 3689.68% from $208.5 million recorded in Q2 2025.
  • In the past 5 years, Wave Life Sciences' Cash & Current Investments ranged from a high of $310.9 million in Q3 2024 and a low of $88.5 million during Q4 2022
  • Its 5-year average for Cash & Current Investments is $181.8 million, with a median of $173.0 million in 2023.
  • As far as peak fluctuations go, Wave Life Sciences' Cash & Current Investments crashed by 4273.51% in 2021, and later skyrocketed by 12639.3% in 2023.
  • Over the past 5 years, Wave Life Sciences' Cash & Current Investments (Quarter) stood at $150.6 million in 2021, then crashed by 41.22% to $88.5 million in 2022, then soared by 126.39% to $200.4 million in 2023, then skyrocketed by 50.77% to $302.1 million in 2024, then crashed by 35.04% to $196.2 million in 2025.
  • Its last three reported values are $196.2 million in Q3 2025, $208.5 million for Q2 2025, and $243.1 million during Q1 2025.